TARA
Protara Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
+0.43%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.37
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.36
- EPS estimate
- -$0.33
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.33 | -$0.36 | Miss -10.53% | — |
| May 19, 2026 | -$0.36 | -$0.31 | Beat 13.89% | — |
| Mar 10, 2026 | -$0.31 | -$0.38 | Miss -20.70% | — |
| May 8, 2025 | -$0.47 | -$0.29 | Beat 38.30% | — |
| Mar 5, 2025 | -$0.57 | -$0.48 | Beat 15.79% | — |
| May 2, 2024 | -$0.99 | -$0.97 | Beat 2.02% | — |
| Mar 13, 2024 | -$1.03 | -$0.90 | Beat 12.62% | $1.2M |
| Nov 3, 2023 | -$1.10 | -$0.87 | Beat 20.91% | — |
| Aug 3, 2023 | -$0.97 | -$1.00 | Miss -3.09% | — |
| May 4, 2023 | -$1.00 | -$0.80 | Beat 20.00% | — |
| Mar 8, 2023 | -$0.77 | -$0.84 | Miss -9.09% | — |
| Nov 3, 2022 | -$0.85 | -$0.68 | Beat 20.00% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026